Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Isologic Radiopharmaceuticals

Isologic Radiopharmaceuticals
PRIVATE STATUS
2ndary - Private LATEST DEAL TYPE
2 FINANCING ROUNDS
1 INVESTMENTS
Description

Opeartor of a radiopharmaceutical company focusing on diagnostic testing and therapeutic treatments. The company utilizes significant experience, expertise and networks in nuclear pharmacy, offering its customers and patients with reliable; safe and high-quality radiopharmaceutical products and services.

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Clinics/Outpatient Services
Primary Office
  • 11215 Côte-de-Liesse
  • Dorval, Quebec H9P 1B1
  • Canada

Isologic Radiopharmaceuticals Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Isologic Radiopharmaceuticals‘s full profile, request access.

Request full access to PitchBook

Isologic Radiopharmaceuticals Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 (00000000 13-Jan-2016 000000000000000000 00.00 Drug Discovery 000000000 00000000
To view this company’s complete investment and acquisition history, request access »

Isologic Radiopharmaceuticals Executive Team (2)

Name Title Board
Seat
Contact
Info
David Paradis Vice President, Finance
Christine Heneault Vice President, Sales & Marketing